JapanJapanese pharmaceutical company Takeda Pharmaceutical has received approval from India's regulatory body for its dengue vaccine, Qdenga, making it the first such vaccine to gain approval in the country. The vaccine was developed to combat a disease that affected approximately 120,000 people in India during the previous year. Takeda is now seeking to include Qdenga in India's national immunization program, according to a senior company executive. This development marks a significant milestone in the fight against dengue in India.
Bias read (Center): The article presents factual information regarding the approval of a dengue vaccine by India's regulatory authority and Takeda's plans to integrate it into the national immunization program. There is no overt ideological framing or emphasis on specific political agendas. The tone remains neutral, as
